Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety, tolerability, and anti-tumor activity of olmutinib in non-small cell lung cancer with T790M mutation: A single arm, open label, phase 1/2 trial.
Kim DW, Lee DH, Han JY, Lee J, Cho BC, Kang JH, Lee KH, Cho EK, Kim JS, Min YJ, Cho JY, An HJ, Kim HG, Lee KH, Kim BS, Jang IJ, Yoon S, Han O, Noh YS, Hong KY, Park K. Kim DW, et al. Among authors: hong ky. Lung Cancer. 2019 Sep;135:66-72. doi: 10.1016/j.lungcan.2019.07.007. Epub 2019 Jul 9. Lung Cancer. 2019. PMID: 31447004 Clinical Trial.
Development and feasibility of an mHealth intervention for psychoeducational support of Nigerian women diagnosed with breast cancer undergoing chemotherapy: A pilot randomized controlled trial.
Akingbade O, Hong KY, Ayo OS, Alade AS, Lawal MA, Somoye IE, Adediran V, Sado O, Chow KM. Akingbade O, et al. Among authors: hong ky. PLoS One. 2024 Nov 25;19(11):e0314365. doi: 10.1371/journal.pone.0314365. eCollection 2024. PLoS One. 2024. PMID: 39585879 Free PMC article. Clinical Trial.
Host genetic and immune factors drive evasion of HIV-1 pathogenesis in viremic non-progressors.
Bayón-Gil Á, Hernández I, Dalmau J, Nieto JC, Urrea V, Garrido-Sanz L, Caratú G, García-Guerrero MC, Gálvez C, Salgado M, Erkizia I, Laguía F, Resa-Infante P, Massanella M, Tonda R, Morata J, Hong KY, Koshy J, Goldman AR, Giron L, Abdel-Mohsen M, Heyn H, Martinez-Picado J, Puertas MC. Bayón-Gil Á, et al. Among authors: hong ky. Med. 2024 Oct 15:100518. doi: 10.1016/j.medj.2024.09.007. Online ahead of print. Med. 2024. PMID: 39413785 Free article.
Circulating immune and plasma biomarkers of time to HIV rebound in HIV controllers treated with vesatolimod.
Abdel-Mohsen M, Deeks S, Giron L, Hong KY, Goldman A, Zhang L, Huang SSY, Verrill D, Guo S, Selzer L, de Vries CR, Vendrame E, SenGupta D, Wallin JJ, Cai Y. Abdel-Mohsen M, et al. Among authors: hong ky. Front Immunol. 2024 Jun 24;15:1405348. doi: 10.3389/fimmu.2024.1405348. eCollection 2024. Front Immunol. 2024. PMID: 38979421 Free PMC article. Clinical Trial.
122 results